Concepedia

Fei Duan

FD

Statistics

Publications

39

Citations

3.2K

H-Index

23

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Xiamen University

Peking University

Hebei University

ARC Centre of Excellence in Advanced Molecular Imaging

Fei Duan is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2003–2025

39

Publications

39

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

Fei Duan, Jorge Duitama, Sahar Al Seesi et al. · The Journal of Experimental Medicine · 2014 · 395 citations

Life Sciences, Immunology, Oncology +17

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton et al. · Nature · 2022 · 332 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Jianjun Gao, Neema Navai, Omar Alhalabi et al. · Nature Medicine · 2020 · 313 citations · Full text

Medicine, Oncology, Urology +14

Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

Adam D. Cohen, David Schaer, Cailian Liu et al. · PLoS ONE · 2010 · 256 citations · Full text

Life Sciences, Immunology, Oncology +17

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao et al. · The Lancet. Gastroenterology & hepatology · 2022 · 256 citations · Full text

Pharmacy, Oncology, Perioperative Medicine +15

1–5 of 39